2016 Q4 Form 10-K Financial Statement

#000143774917005720 Filed on March 31, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2016 2015 Q4
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.800M $3.800M $10.88M
YoY Change -65.06% -35.59% 171.93%
Cash & Equivalents $3.800M $3.800M $5.876M
Short-Term Investments $4.087M $5.002M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $100.0K
Other Receivables $100.0K $100.0K $0.00
Total Short-Term Assets $3.900M $3.900M $6.000M
YoY Change -35.0% -35.0% 30.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.100M $4.100M $5.000M
YoY Change -18.0% -18.0% -16.67%
Other Assets $31.00M $31.00M $47.00M
YoY Change -34.04% -34.04% 147.37%
Total Long-Term Assets $35.10M $35.10M $51.89M
YoY Change -32.36% -32.37% 32.04%
TOTAL ASSETS
Total Short-Term Assets $3.900M $3.900M $6.000M
Total Long-Term Assets $35.10M $35.10M $51.89M
Total Assets $39.00M $39.00M $57.89M
YoY Change -32.63% -32.64% 31.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $400.0K $500.0K
YoY Change -20.0% -20.0% -28.57%
Accrued Expenses $200.0K $200.0K $400.0K
YoY Change -50.0% -50.0% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $900.0K $900.0K $1.400M
YoY Change -35.71% -35.71% -92.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.900M $9.900M $13.00M
YoY Change -23.85% -23.85% 1344.44%
Total Long-Term Liabilities $9.900M $9.900M $13.00M
YoY Change -23.85% -23.85% 1344.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $900.0K $900.0K $1.400M
Total Long-Term Liabilities $9.900M $9.900M $13.00M
Total Liabilities $10.90M $10.90M $14.44M
YoY Change -24.5% -24.31% -29.23%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.10M $28.10M $43.50M
YoY Change
Total Liabilities & Shareholders Equity $39.00M $39.00M $57.90M
YoY Change -32.64% -32.64% 31.89%

Cashflow Statement

Concept 2016 Q4 2016 2015 Q4
OPERATING ACTIVITIES
Net Income
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
224617
CY2016Q2 dei Entity Public Float
EntityPublicFloat
15609374
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q4 gyro Accrued Directors Fees
AccruedDirectorsFees
CY2015Q4 gyro Accrued Directors Fees
AccruedDirectorsFees
52910
CY2014Q2 gyro Additional Bonus Pool Funding Additional Percentage Of Gross Sales Price On Property Appreciation
AdditionalBonusPoolFundingAdditionalPercentageOfGrossSalesPriceOnPropertyAppreciation
0.02
CY2014Q2 gyro Additional Bonus Pool Funding Percentage Of Gross Sales Price On First Ten Percent Of Property Appreciation
AdditionalBonusPoolFundingPercentageOfGrossSalesPriceOnFirstTenPercentOfPropertyAppreciation
0.1
CY2014Q2 gyro Additional Bonus Pool Funding Percentage Of Gross Sales Price On Property Appreciation Greater Than Twenty Percent
AdditionalBonusPoolFundingPercentageOfGrossSalesPriceOnPropertyAppreciationGreaterThanTwentyPercent
0.2
CY2014Q2 gyro Additional Bonus Pool Funding Percentage Of Gross Sales Price On Second Ten Percent Of Property Appreciation
AdditionalBonusPoolFundingPercentageOfGrossSalesPriceOnSecondTenPercentOfPropertyAppreciation
0.15
CY2014Q2 gyro Bonus Pool Funding As Percentage Of Appraised Value Of Contributed Properties
BonusPoolFundingAsPercentageOfAppraisedValueOfContributedProperties
0.05
CY2016 gyro Marketable Securities Adjusted Duration
MarketableSecuritiesAdjustedDuration
P4Y
CY2015 gyro Marketable Securities Adjusted Duration
MarketableSecuritiesAdjustedDuration
P4Y
CY2016 gyro Marketable Securities Contractual Maturities
MarketableSecuritiesContractualMaturities
P30Y
CY2015 gyro Marketable Securities Contractual Maturities
MarketableSecuritiesContractualMaturities
P30Y
CY2016 gyro Marketable Securities Estimated Yield
MarketableSecuritiesEstimatedYield
0.02
CY2015 gyro Marketable Securities Estimated Yield
MarketableSecuritiesEstimatedYield
0.02
CY2016 gyro Number Of Major Customers
NumberOfMajorCustomers
3
CY2015 gyro Number Of Major Customers
NumberOfMajorCustomers
3
CY2016 gyro Percentage Of Mortgage Backed Securities Sold
PercentageOfMortgageBackedSecuritiesSold
1
CY2016 gyro Percentage Of Owned Subsidiaries Nontaxable
PercentageOfOwnedSubsidiariesNontaxable
1
CY2016Q4 gyro Proceeds In Excess Of Fair Value
ProceedsInExcessOfFairValue
15000
gyro Real Estate Heldforsale Period Increase Decrease
RealEstateHeldforsalePeriodIncreaseDecrease
2260000
CY2016 gyro Real Estate Heldforsale Period Increase Decrease
RealEstateHeldforsalePeriodIncreaseDecrease
2336000
CY2014Q2 gyro Retention Bonus Plan Gross Selling Price Requirement Percentage
RetentionBonusPlanGrossSellingPriceRequirementPercentage
1
CY2015Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
408898
CY2016Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
29930
CY2015Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
24314
CY2016Q2 gyro Total Compensation Expense And Directors Fees
TotalCompensationExpenseAndDirectorsFees
233200
CY2015Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
11162
CY2016Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
153992
CY2015Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
245637
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
101442
CY2016Q4 us-gaap Deferred Compensation Arrangement With Individual Distributions Paid
DeferredCompensationArrangementWithIndividualDistributionsPaid
1254248
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1272392
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
14000000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
49000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
50000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
44000
CY2016 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5000
CY2015 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
4087231
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
5001722
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1482680
CY2016Q4 us-gaap Contractual Obligation
ContractualObligation
677100
CY2016Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
CY2015Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
28490
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20.</div>&nbsp; Contingencies </div> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp; </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Putative Class Action Lawsuit</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> a purported stockholder of the Company filed a putative class action lawsuit against Gyrodyne Company of America, Inc. (the &#x201c;Corporation&#x201d;) and members of its Board of Directors (the &quot;Individual Defendants&quot;), and against GSD and the Company (collectively, the &quot;Defendants&quot;), in the Supreme Court of the State of New York, County of Suffolk (the &quot;Court&quot;), captioned <div style="display: inline; font-style: italic;">Cashstream Fund v. Paul L. Lamb, et al.</div>, Index No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">065134/2014</div> (the &quot;Action&quot;).&nbsp; The complaint alleged, among other things, that (i) the Individual Defendants breached their fiduciary duties or aided and abetted the breach of those duties in connection with the merger of the Corporation and GSD into the Company (the &#x201c;Merger&#x201d;) and (ii) the Corporation and the Individual Defendants breached their fiduciary duties by failing to disclose material information in the proxy statement/prospectus relating to the Merger.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the parties to the Action entered into a Stipulation of Settlement (the &quot;Settlement&quot;) providing for the settlement of the Action, subject to the Court's approval.&nbsp; Under the Settlement,&nbsp;Gyrodyne amended its Proxy Statement on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> with certain supplemental disclosures, and agreed that any sales of its properties would be effected only in arm's-length transactions at prices at or above their appraised values as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014.</div>&nbsp; The plaintiff, on behalf of itself and the members of the putative class it represents, agreed to release and dismiss with prejudice all claims that had or could have been asserted in the Action or in any other forum against the Defendants and their affiliates and agents arising out of or relating to the Merger and the other transactions alleged by plaintiff in&nbsp;its complaint, as supplemented.&nbsp; On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Court entered a Final Order and Judgment approving the Settlement. By order of the same date, the Court also granted plaintiff&#x2019;s application for an award of attorney&#x2019;s fees and reimbursement of expenses in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$650,000</div> which was paid in full in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> aggregate appraised value of Gyrodyne&#x2019;s&nbsp;properties was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000</div> higher than the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013</div> aggregate appraised value for such properties. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the aggregate value of the remaining unsold properties was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$550,000</div> lower than the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> appraised value.</div> </div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">GYRODYNE, LLC </div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">AND SUBSIDIARIES</div></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;&nbsp; </div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 100%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Notes to Consolidated Financial Statements</div></div></div></td> </tr> <tr> <td style="WIDTH: 100%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Year Ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and the period <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Amounts related to number of buildings, square footage, occupancy and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">tenant</div> data are unaudited</div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"></div></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">General</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the normal course of business, the Company is a party to various legal proceedings. After reviewing all actions and proceedings pending against or involving the Company, management considers that any loss resulting from such proceedings individually or in the aggregate will not be material to the Company&#x2019;s financial statements.</div> </div></div>
CY2016Q4 us-gaap Marketable Securities
MarketableSecurities
4087231
CY2015Q4 us-gaap Marketable Securities
MarketableSecurities
5001722
CY2016Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
131758
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
40695
CY2015Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
57547
CY2016 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
881066
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
281606
CY2015Q3 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
45450000
CY2015Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
46950000
CY2014Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
45450000
CY2016Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
31025000
CY2016 us-gaap Reclassifications
Reclassifications
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22.</div>&nbsp; Reclassifications:</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 45pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 13.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain amounts in the prior period have been reclassified to conform to the classification used in the current period. Prepaid expenses and other assets have been netted against estimated liquidation and operating costs net of receipts on the statement of net assets.</div></div></div>
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Management Estimates </div></div>&#x2013; In preparing the consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) and the liquidation basis of accounting, management is required to make estimates and assumptions that affect the reported amounts of assets, including net assets in liquidation, and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of receipts and expenditures for the reporting period.&nbsp;&nbsp;Actual results could differ from those estimates.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The most significant estimates are the estimates on the net realizable value from the sale of our real estate, the estimated costs/time to pursue entitlements/change of zone and the related timeline to complete the liquidation.</div></div></div></div></div></div></div></div></div></div>

Files In Submission

Name View Source Status
0001437749-17-005720-index-headers.html Edgar Link pending
0001437749-17-005720-index.html Edgar Link pending
0001437749-17-005720.txt Edgar Link pending
0001437749-17-005720-xbrl.zip Edgar Link pending
ex10-4.htm Edgar Link pending
ex21.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gyrllc20161231_10k.htm Edgar Link pending
gyro-20161231.xml Edgar Link completed
gyro-20161231.xsd Edgar Link pending
gyro-20161231_cal.xml Edgar Link unprocessable
gyro-20161231_def.xml Edgar Link unprocessable
gyro-20161231_lab.xml Edgar Link unprocessable
gyro-20161231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending